Ask Drs. E&P: Can You Use Afrezza with AID Systems?

By on January 22, 2026   /   Afrezza, Ask Dr. E, Inhaled Insulin, Pumps   /   14 Comments
Two men hold whiteboards – one man’s whiteboard reads “Afrezza” as he holds an Afrezza inhaler device. The other man holds a board labeled “Insulin Pump.”

Although Afrezza isn’t officially approved for use with AID systems, Dr. Edelman and Dr. Pettus use it all the time, and they prescribe it to many of their patients who are on pumps. Learn how inhaled insulin can be a compliment to AID systems, when it works best, and when you need to be cautious.

[read_more text="read more" title="read more" url="https://tcoyd.org/2026/01/afrezza-with-aid-systems/" align="left"]
[divider_top]

Dr. E’s Case Study: If Your Morning Blood Sugars Could Talk, They’d Say “Give Me a Break!”

By on June 17, 2025   /   A1c, Afrezza, Case Studies, Hyperglycemia, Inhaled Insulin, Insulin Resistance   /   11 Comments
Man with diabetes checking his high blood sugars in the morning

Are your blood sugar spikes the worst after breakfast than other times of the day? Discover why normal, everyday hormones might be to blame, and how inhaled insulin can help you take back control. Taking a “hit” is common now – without the risk of being arrested!

[read_more text="read more" title="read more" url="https://tcoyd.org/2025/06/morning-blood-sugar-spikes/" align="left"]
[divider_top]

Once-Weekly Basal Insulins: Better Blood Sugars with Fewer Injections

By on March 25, 2024   /   Basal Insulin in Type 1, Basal Insulin in Type 2, Insulin, Type 2   /   7 Comments
Weekly insulin injection schedule for type 2 diabetes management.

With Novo Nordisk’s weekly basal insulin submission getting close to a decision by the FDA, this ground-breaking insulin therapy could pave the way for a significantly reduced diabetes management burden for millions of people with type 2 diabetes.

[read_more text="read more" title="read more" url="https://tcoyd.org/2024/03/once-weekly-basal-insulins-better-blood-sugars-with-fewer-injections/" align="left"]
[divider_top]

Size Matters! All About Needles and Multiple Daily Injections

By on April 28, 2023   /   A Dose of Dr. E, Insulin, Multiple Daily Injections   /   11 Comments
May 2023 Dose of Doctors E and P on MDI

Are you a rule follower or are you a rebel when it comes to injections? Do you faithfully use alcohol wipes, or do you casually stick yourself through your shirt? Drs. E+P share which injection rules are okay to break, and which ones to follow. They discuss proper technique, needle size, lipohypertrophy, and a unique methodology Dr. E invented himself that’s now on Wikipedia!

[read_more text="read more" title="read more" url="https://tcoyd.org/2023/04/size-matters-all-about-needles-and-multiple-daily-injections/" align="left"]
[divider_top]

Lilly, Novo Nordisk, and Sanofi Cut Insulin Prices: A Pivotal Moment for Insulin Affordability

By on April 27, 2023   /   Insulin, Insurance, Medicare   /   Leave a comment
Insulin Price Reductions

Insulin affordability has been a critical issue for many people with diabetes for years, but the three largest insulin manufacturers in the U.S. recently reduced insulin prices.

[read_more text="read more" title="read more" url="https://tcoyd.org/2023/04/novo-nordisk-sanofi-and-lilly-cut-insulin-prices-a-pivotal-moment-for-insulin-affordability/" align="left"]
[divider_top]